'Personalised medicine' is the topic of a free public lecture at the University of Greenwich.
Personalised medicine, or precision medicine, as it is sometimes known, is a key goal for 21st century healthcare. Currently, many medicines are either ineffective or unsafe in certain patient populations, whereas the aim for personalised medicine is to target the right treatment to the right patient group.
The talk by Jeremy Everett, the university's Professor of Pharmaceutical Technologies, takes place at the Medway Campus on Wednesday 30 October, and is the latest in the Faculty of Engineering & Science public lecture series.
In Personalised Medicine: Getting the Right Medicine to the Right Patient, Professor Everett will examine its meaning and reveal new insights into the ways in which the bacteria that we carry in and on our bodies can affect our health and our response to medicines.
He says: "We know that many medicines are not effective or not safe in all patients. This lecture will review new ways, beyond genomics, that we can use to help choose medicines that are both efficacious and safe for patient populations in the future."
An internationally recognised expert on drug discovery and in predicting how individuals will respond to drug treatment, Professor Everett is the author of more than 80 publications and reviews. Prior to joining Greenwich three years ago, he held a variety of technology leadership positions for Pfizer, SmithKline Beecham and Beecham Research Laboratories.
He has strong research interests in profiling the substances found in human biofluids such as urine and plasma, an area of science known as metabonomics. Professor Everett is also a Visiting Professor in the Department of Surgery and Cancer at Imperial College.
The lecture will be held in the university's Pembroke Building and will begin at 6.30pm. Admission is by registration only, with places allocated on a first-come, first-served basis.